In the urgent space between consciousness and the breathing tube, clinicians have long sought certainty where medicine offers only trade-offs. A large American multicenter trial enrolling 2,365 critically ill adults compared ketamine and etomidate for rapid sequence intubation, hoping to resolve a debate that has shaped emergency and intensive care practice for years. The study found equivalent 28-day mortality between the two drugs, yet revealed that ketamine carries a meaningfully higher risk of immediate cardiovascular collapse — particularly in the sickest patients. The question of which d
Ketamine vs. Etomidate for Rapid Sequence Intubation: No Clear Winner
Related Coverage
Plataforma digital conecta produtores rurais a máquinas agrícolas ociosas, gerando R$ 5 milhões anuais e democratizando …
G1 · Aug 26 Violência doméstica funciona em ciclos de tensão, agressão e falso arrependimentoEspecialistas explicam que violência doméstica segue padrão cíclico de tensão, agressão e arrependimento, dificultando q…
G1 · Aug 26 Adesivos para espinha ganham versão colorida e viram acessório de modaAdesivos para espinha evoluem de discretos para coloridos e decorativos, mantendo função terapêutica de proteção e cicat…
Google News · Aug 26 CVM aprova oferta pública de ações na Oncoclínicas em decisão polêmicaA CVM aprovou a oferta pública de ações da Oncoclínicas em julgamento de R$ 6 bilhões, contrariando parecer da área técn…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
Medical study on anesthetic agents for intubation has no geopolitical implications; this is a clinical research article, not a geopolitical matter.
Economic Lens
Randomized trial of 2,365 critically ill patients shows ketamine and etomidate have similar 28-day mortality for rapid intubation, but ketamine increases cardiovascular collapse risk, with no clear clinical winner.
Patients requiring emergency intubation will continue to have drug selection based on individual clinical factors rather than mortality advantage. Healthcare costs may remain stable as both drugs are likely similarly priced, but hospitals may adjust protocols based on cardiovascular stability concerns.
Medical societies may need to update clinical guidelines to emphasize individualized drug selection rather than universal recommendations. Hospitals may implement risk-stratification protocols to guide ketamine vs. etomidate use based on patient sepsis status and APACHE scores. Potential for increased monitoring requirements if ketamine use continues.